Search

Search Constraints

You searched for: Author/Creator Douglas, Mark W.

Search Results

2. Diverse impacts of the rs58542926 E167K variant in TM6SF2 on viral and metabolic liver disease phenotypes. Issue 1 (30th March 2016)

3. Global multi-stakeholder endorsement of the MAFLD definition. (May 2022)

5. Impact of an Open Access Nationwide Treatment Model on Hepatitis C Virus Antiviral Drug Resistance. Issue 6 (6th April 2020)

7. Rapid and persistent decline in soluble CD163 with successful direct-acting antiviral therapy and associations with chronic hepatitis C histology. (3rd August 2018)

8. Sequencing of hepatitis C virus for detection of resistance to direct‐acting antiviral therapy: A systematic review. Issue 5 (22nd May 2017)